[R01] Understanding and Therapeutic Targeting of Extramedullary Acute Leukemia
Ente: National Cancer Institute
Scadenza: 2031-04-30
Importo max: $716,681
Paese: US
Descrizione
PROJECT SUMMARY/ABSTRACT
Myeloid sarcoma (MS) is a subtype of acute myeloid leukemia (AML) found in ~5-10% of patients. In MS, myeloid
blasts form solid tumor-like, invasive masses in multiple extramedullary sites, including the skin, the lymph nodes,
and the gastrointestinal tract. MS is a heteroge
Settori: National Cancer Institute
Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.